Navigation Links
Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design

MOUNTAIN VIEW, Calif., July 23, 2012 /PRNewswire/ -- Based on its recent analysis of the medical implantable textile structures design market, Frost & Sullivan recognizes Secant Medical® with the 2012 North American Frost & Sullivan Award for Enabling Technology. Combining variability in structure, delivery method, performance, physical composition, resorbability, and other unique elements that make up implantable textile constructions, Secant Medical's customized approach enables medical device manufacturers to develop a portfolio of more innovative, effective, and commercially successful medical device designs.

Secant Medical is one of the few suppliers that can provide customized design solutions at competitive prices to medical device manufacturers and other notable clients in the biomedical device industry.

"There is an emerging industry need to completely understand the role that material selection plays in realizing component structure design, optimizing the development process, and largely defining the form and function of the end device," said Frost & Sullivan Senior Research Analyst Prasanna Vadhana Kannan. "One of the unique approaches adopted by Secant Medical toward design methodology is its ability to understand the medical device design requirements and leverage its technology to create a customized solution for the client's device application."

A right combination of established and emerging novel substrates, along with a carefully structured material selection process, offers an effective path toward enhancing the performance of a medical device design. In line with this trend, Secant Medical is focused on advancing textile constructs built from absorbable and bio-active polymers for tissue engineering and orthobiologics applications that require short-term tissue support while the body repairs itself, followed by long-term biologic integration.

The company's approach will also enable niche applications for biomedical textiles. For instance, Frost & Sullivan expects that in the near future, spinal applications will benefit from woven structures that contain reinforced holes for screws and other fixative components used for attaching to a bone plate. In effective filtration-involving applications, weaving with wires and other biomaterials paves the way for more open constructions that have highly controlled pore sizes for capturing emboli, while at the same time allowing normal blood flow through the material. Such prospects of woven biomedical textiles are useful in surgical techniques involving high-stroke patients. As such, the potential for Secant's technology is far-reaching.

"Another crucial capability in woven biomedical textiles is the ability to provide vital properties by altering or modulating the geometry of the structures and the materials from which they are produced," noted Prasanna Vadhana Kannan. "Secant Medical is working toward textile components engineered from materials designed to degrade at varying rates over time, thereby allowing the ability to fine-tune fabric degradation in sync with the desired tissue healing rate of the patient."

Further, Secant Medical has formed strategic partnerships with leading biomaterial providers in order to boost the innovation in the orthopedics segment involving tissue engineering, tissue scaffolding, and orthobiologics concepts. The firm realizes that with a seemingly endless need to customize materials and form technologies to suit new device applications, investing in biomedical textiles R&D will accelerate innovation and advance medical technologies available for surgical procedures.

For being a forward-thinking supplier that works toward the device manufacturer's needs in a constantly evolving industry, Secant Medical is the worthy recipient of the 2012 North America Frost & Sullivan Award for Enabling Technology in the implantable textile structures design market.

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of newer products and applications. The award recognizes the high market acceptance potential of the recipient's technology.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Secant Medical

Secant Medical, established in 2002 as a business unit within Prodesco Inc. (part of Fenner PLC), pioneers cutting-edge technologies in the biomedical textiles domain.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion

Join Us: Join our community

Subscribe: Newsletter on "the next big thing"

Register: Gain access to visionary innovation


Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003


SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Somnetics Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence
2. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
3. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
4. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
5. Frost & Sullivan: Label-Free Technology is a High Potential Market with Myriad Unexplored Applications
6. Frost & Sullivan: Next-Generation Sequencing Services is one of the Fastest Growing Markets in the Life Sciences Industry
7. Need for Reduced Healthcare Outlays Creates Strong Growth Potential for Medical Imaging Services, Says Frost & Sullivan
8. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
9. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
11. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)... MELVILLE, N.Y. , Nov. 25, 2015  Henry ... products and services to office-based dental, medical and animal ... Dental (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion ... industry,s broadest array of open solutions designed to help ... Click here for a schedule of ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is ... Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College ... as only one of twelve colleges and universities in the state of California make ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) ... supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Travel Representative. As a franchise owner, Somu now offers travelers, value and care ... wedding packages, private cruise sales, as well as, cabin upgrades and special amenities ...
Breaking Medicine News(10 mins):